Treace Medical Concepts

What Treace Medical Concepts does

Treace Medical Concepts, Inc. is a medical technology company that develops and commercializes proprietary surgical systems for the correction of bunion and midfoot deformities, headquartered in Ponte Vedra Beach, Florida, and traded on NASDAQ under ticker TMCI since its April 2021 IPO. The company's portfolio is anchored by the patented Lapiplasty 3D Bunion Correction System, which uses a 'Correct Before You Cut' methodology to address all three planes of bunion deformity and secure the unstable first tarsometatarsal joint. Adjacent systems include Adductoplasty for midfoot correction, IntelliGuide patient-specific 3D-printed titanium cut guides, SpeedPlate/SpeedMTP/SpeedAkin rapid compression implants, SuperBite compression screws, and minimally invasive variants Nanoplasty (1.5 cm incision) and Percuplasty (percutaneous), supported by sterile-packed single-use instruments and biologic wedges.

The company sells exclusively to healthcare providers in the United States through a direct field sales organization covering defined geographic territories, with 3,337 active surgeons as of the most recent disclosure. Pricing is negotiated through group purchasing organization (GPO) contracts and institutional purchasing agreements with hospitals and ambulatory surgery centers; no public list pricing exists. Revenue is hardware sales of surgical implants and instruments, with FY2025 revenue of $212.7 million (up 2% YoY) at an 80.6% gross margin, though Q1 2026 revenue declined 10% YoY to $47.2 million and management has guided FY2026 to $202–212 million. The company operates at a net loss ($59.0M in FY2025; $18.0M in Q1 2026) and carries over 50 granted US patents protecting its core systems and instrumentation. In December 2025, Treace secured a $175 million debt facility from SLR Capital Partners to refinance and fund expansion.

Name

Treace Medical Concepts

Legal name

Treace Medical Concepts, Inc.

Website

https://treace.com

Company type

Public

Founded year

2014

Operating status

Operating

Headcount range

251–500 employees

Short description

Treace Medical Concepts is a US medical device company that develops and sells proprietary surgical systems — led by the patented Lapiplasty 3D Bunion Correction System — for the correction of bunion and midfoot deformities, selling directly to a base of over 3,300 foot and ankle surgeons through hospitals and ambulatory surgery centers.

Ownership category

akta.pro rank

Product category

Orthopedic Foot and Ankle Surgical Devices

NAICS

Surgical Appliance and Supplies Manufacturing (339113), Surgical and Medical Instrument Manufacturing (339112)

SIC

Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Orthopedic Trauma & Extremities Fixation (Plates/Screws/Nails/External Fixation) (HLAHAEAB)

akta.pro secondary industries

Open & Minimally Invasive Surgical Instruments (Handheld, Laparoscopic, MIS) (HLAHADAA), Orthopedic Joint Reconstruction Implants (Hip/Knee/Shoulder/Elbow/Ankle) (HLAHAEAA)

Keywords

• Foot and ankle surgery
• Bunion correction systems
• Midfoot deformity correction
• Orthopedic surgical implants
• Minimally invasive bunion surgery

Headquarters

HQ city

Ponte Vedra Beach

HQ country

United States

HQ region

North America

Offices6 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Supply Chain, Infrastructure

Revenue model

1. Surgical Implants and Instruments: Treace Medical Concepts generates revenue through the sale of proprietary surgical implant systems and instruments for bunion and midfoot deformity correction. Revenue declined 10% year-over-year in Q1 2026 to $47.2 million, with full-year 2025 revenue of $212.7 million. The company operates with net losses, posting $(18.0) million net loss in Q1 2026 and $(59.0) million full-year 2025 net loss.

Pricing tiers

Go-to-market motion2 records

Distribution channels1 record

Marketing channels6 records

Core offering

Treace Medical Concepts designs, manufactures, and sells proprietary surgical implant systems and instruments for the correction of bunion and midfoot deformities. Its flagship Lapiplasty 3D Bunion Correction System combines patented instruments, implants, and methods to address all three planes of bunion deformity, complemented by minimally invasive systems (Nanoplasty, Percuplasty, Micro-Lapiplasty), compression implants (SpeedPlate, SpeedMTP, SpeedAkin), patient-specific cut guides (IntelliGuide), and sterile single-use instruments.

Product overview

Treace Medical Concepts is a medical technology company offering a comprehensive portfolio of surgical systems for bunion and midfoot deformity correction. The core offerings include the Lapiplasty 3D Bunion Correction System (the foundational patented system addressing triplanar bunion correction), the Adductoplasty Midfoot Correction System, and two minimally invasive options: the Nanoplasty 3D MIS System (1.5cm incision) and Percuplasty Percutaneous System. These are complemented by rapid compression implant platforms (SpeedPlate, SpeedMTP, SpeedAkin) and the SuperBite Compression Screw System. Add-on modules include IntelliGuide Patient-Specific cut guides and sterile-packed single-use instruments. The portfolio addresses the full spectrum of bunion correction procedures from open to minimally invasive approaches.

Differentiator

Problem solved

Functional benefit

Brands

• Lapiplasty: 3D Bunion Correction System - combination of instruments, implants, and surgical methods designed to surgically correct all three planes of bunion deformity
• Adductoplasty
• SpeedMTP
• Nanoplasty
• Percuplasty
• SpeedPlate
• IntelliGuide
• SuperBite
• SpeedAkin
• Micro-Lapiplasty
• Mini-Adductoplasty
• HyperPlate XM
• SpeedTMT

Products and services

• Lapiplasty 3D Bunion Correction System Combination of instruments, implants, and surgical methods designed to surgically correct all three planes of bunion deformity and secure the unstable joint, addressing the root cause of bunions for foot and ankle surgeons.
• Adductoplasty Midfoot Correction System Designed for reproducible surgical correction of midfoot deformities including adductus deformity and osteoarthritis using controlled planning, cutting, compression, and fixation.
• Nanoplasty 3D MIS Bunion Correction System Minimally invasive 3D bunion correction through a hidden 1.5 cm incision with predictability at every step, eliminating the steep learning curve of traditional MIS techniques.
• Percuplasty Percutaneous 3D Bunion Correction System Percutaneous approach to 3D bunion correction providing control and efficiency at every step with an ultra-low-profile jig for optimal visualization.
• SpeedMTP Rapid Compression Implant Delivers speed and dynamic compression of a staple with the stability and strength of a titanium locking plate for first MTP fusion procedures, featuring an ultra-low-profile 1.3mm design.
• SpeedPlate Rapid Compression Implant Market-leading rapid compression implant offering continuous dynamic compression across fusion sites with anatomic designs, manufactured from titanium alloy without nickel.
• SpeedAkin Anatomic Compression Implant Unique anatomic contoured design that delivers flush dynamic compression through an efficient simple workflow for hallux (Akin) procedures.
• IntelliGuide Patient-Specific 3D Cut Guides First patented patient-specific 3D printed titanium cut guides for personalized 3D bunion and midfoot correction, customized to each patient's unique anatomy.
• SuperBite Compression Screw System Fully threaded compression screws powered by continuously variable thread pitch and optimized head design for advanced compression and stability in foot and ankle surgeries.
• Micro-Lapiplasty Minimally Invasive System Delivers the triplanar correction of Lapiplasty through a 2 cm incision using SpeedPlate technology, maximizing cosmesis without compromising correction.
• Mini-Adductoplasty Minimally Invasive Midfoot Correction Novel cut guide allows for the same reliable correction of midfoot deformities as Adductoplasty through a 4 cm incision.
• Sterile-Packed Single-Use Instruments Sterile-packed, single-use instruments including LapiTome, RazorTome, FastGrafter, SpeedRelease, GreatRelease, TriTome, FeatherRasp, and Akinator for foot and ankle surgical procedures.
• Hammertoe PEEK Fixation System Guided PEEK solution for hammertoe, claw toe, and mallet toe procedures.
• Biologics and Wedges Treace Allograft Wedges engineered for strength and correction, and CortiFuse flowable cortical fibers for maximizing healing potential in foot and ankle procedures.
• HyperPlate XM Dynamic Compression Locking Implant System Dynamic compression locking implant system with anatomic design for midfoot and hindfoot fusion procedures.
• SpeedTMT Rapid Compression Implant Rapid compression implant combining staple speed with titanium locking plate stability for foot and ankle fusion procedures.

Quantifiable outcome

• 0.8% radiographic recurrence rate at 48 months (HVA > 20 degrees)
• +6 more outcomes

Named customers9 records

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature8 records

Scale indicators12 records

Recent moves7 records

Expansion highlights4 records

Emerging players

• CONMED: CONMED offers orthopedic and general surgery devices including foot and ankle fixation products, representing a partial overlap with Treace's surgical implant and instrument portfolio.
• Vilex: Vilex is a smaller foot and ankle focused orthopedic device company offering bunion correction and fixation products that compete in adjacent niches to Treace's Lapiplasty system.

Broad incumbents

• Stryker: Stryker is a diversified orthopedic medical device incumbent with broad surgical implant and instrument portfolios across multiple specialties, including foot and ankle through its Wright Medical acquisition, providing overlapping capabilities to Treace's portfolio.
• DePuy Synthes (Johnson & Johnson MedTech): DePuy Synthes is a global orthopedic trauma and reconstruction incumbent offering plates, screws, and surgical instruments applicable to foot and ankle surgery, representing a broader competitive presence than Treace's specialized portfolio.
• Integra LifeSciences: Integra LifeSciences provides orthopedic fixation implants and instruments for extremities, including foot and ankle surgery, competing with Treace in plates, screws, and specialty surgical systems.
• Zimmer Biomet: Zimmer Biomet is a major orthopedic medical device company with broad joint reconstruction, trauma, and surgical implant offerings that overlap with Treace's plates, screws, and fixation products for foot and ankle surgery.
• Smith+Nephew: Smith+Nephew is a global medical device incumbent with an orthopedic portfolio that includes foot and ankle reconstruction products, competing broadly with Treace in the surgical implant and instrument space.

Direct peers

• Paragon 28: Paragon 28 is a pure-play foot and ankle orthopedic medical device company offering a broad portfolio of surgical implants and instruments for foot and ankle reconstruction, making it the closest direct competitor to Treace's bunion and midfoot correction franchise.
• Arthrex: Arthrex is a global leader in orthopedic surgical devices with a dedicated foot and ankle product line that competes directly with Treace's Lapiplasty, Adductoplasty, and minimally invasive bunion correction systems.
• Wright Medical (Stryker Foot & Ankle): Wright Medical, now part of Stryker, has historically been a leading foot and ankle specialist with bunion correction and midfoot reconstruction implants that overlap with Treace's core Lapiplasty offering.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/treace-medical-concepts-llc
• Xx.com/treacemedical
• Facebookfacebook.com/treace-medical-concepts-inc-250527485279319

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles20 records

Funding overview

Funding rounds5 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Treace Medical Concepts